Emerald Health Therapeutics Inc (CVE:EMH) Oversubscribed Offering To Support Expansion


CFN Media Group reported publication of an article showcasing Emerald Health Therapeutics Inc (CVE:EMH) recent public offering and its growth in expanding its operations. The company commenced its public offering earlier in this month and ended up issuing 13.170 million units priced at $1.85 per unit for gross proceeds of around $24.364 million. Just after the initial closing, the firm reported that over-allotment process was a success, adding another $2.758 million in gross proceeds to the offering.

The highlights

Emerald Health reported that the units offered in the public offering comprise one-half of a common stock purchase warrant and one share of common stock. The warrant allows the holder to buy one share of common stock priced at $2.60/share for a 24-month period subsequent the offering. If the firm’s stock surpasses $3.50/share for twenty successive trading sessions, the firm may rush the expiration date to the 30th day once notice is given.

In the last trading session, Emerald Health shares price closed at $1.19, which is far below unit price of $1.85 and the exercise price of $2.60 per share. In other words, shareholders can buy the shares in the open market with 100% gains before the warrants begin to trigger while gaining from the $27 million in capital to support its footprint in the market. The firm’s ~$95 million market capitalization, discounting in shares issued post financing, is modest compared to many other approved producers.

Emerald Health intends to build out its presence in extensive expansions depending on demand. Preliminary, the firm intends to expand its presence to 100,000 square feet this year itself and produce dried cannabis around 10,000 kilograms per year. Its 32-acre asset indicates that it can expand its footprint with up to 1,000,000 square feet of mounting space capable of generating upwards of 100,000 kilograms annually of dried cannabis.

This report is for information purposes only, and is neither a solicitation or recommendation to buy nor an offer to sell securities. Financials Trend is not-a-registered-investment-advisor. Financials Trend is not a broker-dealer. Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. Financials Trend accepts no liability for any losses arising from an investor's reliance on the use of this material. Financials Trend sometimes gets compensated up to one hundred and fifty thousand dollars per month for featuring particular stocks. See site disclaimer for complete compensation. Financials Trend and its affiliates or officers currently hold no shares of these stocks. Financials Trend and its affiliates or officers will purchase and sell shares of common stock of these stocks, in the open market at any time without notice. Financials Trend will not update its purchases and sales of these stocks in any future postings on Financials Trend's websites. Certain information included herein is forward-looking within the context of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. The words "may", "would," "will," "expect," "estimate," "anticipate," "believe," "intend," " project," and similar expressions and variations thereof are intended to identify for ward-looking statements. Such forward- looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. *Financials Trend does not set price targets on securities. Never invest into a stock discussed on this web site or in this email alert unless you can afford to lose your entire investment.